Market Research Logo

Dexcel Pharma - Strategic SWOT Analysis Review

Dexcel Pharma - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

Business description – A detailed description of the company’s operations and business divisions.
Corporate strategy – GlobalData’s summarization of the company’s business strategy.
SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history – Progression of key events associated with the company.
Major products and services – A list of major products, services and brands of the company.
Key competitors – A list of key competitors to the company.
Key employees – A list of the key executives of the company.
Executive biographies – A brief summary of the executives’ employment history.
Key operational heads – A list of personnel heading key departments/functions.
Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Dexcel Pharma (Dexcel) is a pharmaceutical company which develops and markets healthcare products. Its products include Cetirizine, Zyllergy, Alvoran, Betaren, Defanac, Diclofenac, Diclofenac Atid, Aceridex, Aspirin, Cadex, Losartan, Metoprolol Atid, Iomeron, Iopamiro, Periochip, Cemidin, Cimetidine, and Daivobet. Dexcel develops formulations using proprietary, patent-protected, drug delivery technologies. It offers products in the therapeutic areas such as allergy, analgesics, cardiovascular, dental, derma, cosmetics, diabetes, hypertension, digestive, psychiatry, neurology, oncology, infection, and pain relief, among others. The company operates through its subsidiaries such as US, UK and Germany. It also has it manufacturing facilities in Or Akiva, Yokneam and Jerusalem. Dexcel is headquartered in Haifa, Israel.

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.


Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Dexcel Pharma - Key Facts
Dexcel Pharma - Key Employees
Dexcel Pharma - Key Employee Biographies
Dexcel Pharma - Major Products and Services
Dexcel Pharma - Pharmaceutical Pipeline Products Data
Dexcel Pharma, Pipeline Products by Therapy Area
Dexcel Pharma, Pipeline Products by Development Phase
Dexcel Pharma - History
Dexcel Pharma - Company Statement
Dexcel Pharma - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Dexcel Pharma - Business Description
Dexcel Pharma - Corporate Strategy
Dexcel Pharma - SWOT Analysis
SWOT Analysis - Overview
Dexcel Pharma - Strengths
Strength - Patented Technologies Base
Strength - Operational Base
Dexcel Pharma - Weaknesses
Weakness - Reliance on Distributors
Dexcel Pharma - Opportunities
Opportunity - Increasing Opportunities in Emerging Markets
Opportunity - Changing Demographics
Dexcel Pharma - Threats
Threat - Uncertain R&D Outcomes
Threat - Stringent Government Regulations
Threat - Competitive Environment
Dexcel Pharma - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Dexcel Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Dexcel Pharma, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Dexcel Pharma, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Dexcel Pharma, Key Facts
Dexcel Pharma, Key Employees
Dexcel Pharma, Key Employee Biographies
Dexcel Pharma, Major Products and Services
Dexcel Pharma, Number of Pipeline Products by Therapy Area
Dexcel Pharma, Number of Pipeline Products by Development Stage
Dexcel Pharma, Pipeline Products By Therapy Area and Development Phase
Dexcel Pharma, History
Dexcel Pharma, Subsidiaries
Dexcel Pharma, Key Competitors
Dexcel Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Dexcel Pharma, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Dexcel Pharma, Recent Deals Summary
List of Figures
Dexcel Pharma, Pipeline Products by Therapy Area
Dexcel Pharma, Pipeline Products by Development Phase
Dexcel Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Dexcel Pharma, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report